{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:36Z","timestamp":1777984296761,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["ZDXK07224002"],"award-info":[{"award-number":["ZDXK07224002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-04172-8","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:54:44Z","timestamp":1772549684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum Interleukin-39 in Myasthenia gravis: a possible biomarker"],"prefix":"10.1186","volume":"31","author":[{"given":"Kun","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhe","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"4172_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023\u201336.","journal-title":"Lancet Neurol"},{"key":"4172_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08218-3","author":"A Shushtari","year":"2025","unstructured":"Shushtari A, Ashayeri H, Salmannezhad A, Seyedmirzaei H, Rezaei N. Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis. Neurol Sci. 2025. https:\/\/doi.org\/10.1007\/s10072-025-08218-3.","journal-title":"Neurol Sci"},{"key":"4172_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/nyas.13573","volume":"1413","author":"M Yan","year":"2018","unstructured":"Yan M, Xing G, Xiong W, Mei L. Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis. Ann NY Acad Sci. 2018;1413:126\u201335.","journal-title":"Ann NY Acad Sci"},{"key":"4172_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.13502","volume":"1412","author":"I Illa","year":"2018","unstructured":"Illa I, Cortes-Vicente E, Martinez MA, Gallardo E. Diagnostic utility of cortactin antibodies in myasthenia gravis. Ann NY Acad Sci. 2018;1412:90\u20134.","journal-title":"Ann NY Acad Sci"},{"key":"4172_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cei.12840","volume":"186","author":"X Wang","year":"2016","unstructured":"Wang X, Liu X, Zhang Y, Wang Z, Zhu G, Han G, et al. Interleukin (IL)-39 [IL-23p19\/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation\/expansion of neutrophils in lupus-prone mice. Clin Exp Immunol. 2016;186:144\u201356.","journal-title":"Clin Exp Immunol"},{"key":"4172_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.156969","volume":"192","author":"P Ahmadi","year":"2025","unstructured":"Ahmadi P, Janzadeh A, Honardoost M, Taherkhani S, Doyle D, Mojarad N. The role of IL-39 in autoimmune diseases: from general to immunopathogenesis. Cytokine. 2025;192:156969.","journal-title":"Cytokine"},{"key":"4172_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12883-020-01885-z","volume":"20","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li Y, Jiang S, Zhang L, Yi M, Wang J, et al. Increased serum IL-36gamma levels are associated with disease severity in myasthenia gravis patients. BMC Neurol. 2020;20:307.","journal-title":"BMC Neurol"},{"key":"4172_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87:419\u201325.","journal-title":"Neurology"},{"key":"4172_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.surg.2015.12.029","volume":"159","author":"JV Carter","year":"2016","unstructured":"Carter JV, Pan J, Rai SN, Galandiuk S. ROC-ing along: evaluation and interpretation of receiver operating characteristic curves. Surgery. 2016;159:1638\u201345.","journal-title":"Surgery"},{"key":"4172_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.596621","volume":"11","author":"H Frykman","year":"2020","unstructured":"Frykman H, Kumar P, Oger J. Immunopathology of autoimmune myasthenia gravis: implications for improved testing algorithms and treatment strategies. Front Neurol. 2020;11:596621.","journal-title":"Front Neurol"},{"key":"4172_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102800","volume":"20","author":"R Zhao","year":"2021","unstructured":"Zhao R, Luo S, Zhao C. The role of innate immunity in myasthenia gravis. Autoimmun Rev. 2021;20:102800.","journal-title":"Autoimmun Rev"},{"key":"4172_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1680530","volume":"16","author":"K Jia","year":"2025","unstructured":"Jia K, Shao Y, Tan T, Liu X, Zhang Q, Zhao N, et al. Serum Interleukin-40 increases in anti-AchR antibody-positive Myasthenia Gravis and correlates with disease activity. Front Neurol. 2025;16:1680530.","journal-title":"Front Neurol"},{"key":"4172_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5114\/ceji.2020.97911","volume":"45","author":"Z Lu","year":"2020","unstructured":"Lu Z, Xu K, Wang X, Li Y, Li M. Interleukin 39: a new member of Interleukin 12 family. Cent Eur J Immunol. 2020;45:214\u20137.","journal-title":"Cent Eur J Immunol"},{"key":"4172_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2023.110616","volume":"119","author":"L Ying","year":"2023","unstructured":"Ying L, Gong L, Meng S, Wu X, Li M, Li Y. Circulating Interleukin-39 as a potential biomarker for rheumatoid arthritis diagnosis. Clin Biochem. 2023;119:110616.","journal-title":"Clin Biochem"},{"key":"4172_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00286-x","volume":"11","author":"K Lv","year":"2022","unstructured":"Lv K, Hu B, Xu M, Wan L, Jin Z, Xu M, et al. IL-39 promotes chronic graft-versus-host disease by increasing T and B cell pathogenicity. Exp Hematol Oncol. 2022;11:34.","journal-title":"Exp Hematol Oncol"},{"key":"4172_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202509260","volume":"12","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Dong J, Qiu M, Bai J, Cheng X, Song X. Single-cell immune profiling reveals neutrophils promote Myasthenia gravis exacerbation through BAFF secretion. Adv Sci. 2025;12:e09260.","journal-title":"Adv Sci"},{"key":"4172_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-023-05484-3","volume":"28","author":"SS Hassan","year":"2024","unstructured":"Hassan SS, Abdelkawy M, Shaker OG, Tarrad NAF. IL-39 and IL-35 gingival crevicular fluid levels in diabetic patients with generalized periodontitis. Clin Oral Invest. 2024;28:124.","journal-title":"Clin Oral Invest"},{"key":"4172_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.409","volume":"6","author":"SW Nussrat","year":"2023","unstructured":"Nussrat SW, Ad\u2019Hiah AH. Interleukin-39 is a novel cytokine associated with Type 2 Diabetes Mellitus and positively correlated with body mass index. Endocrinol Diabetes Metab. 2023;6:e409.","journal-title":"Endocrinol Diabetes Metab"},{"key":"4172_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm-2016-0361","volume":"11","author":"Y Luo","year":"2017","unstructured":"Luo Y, Liu F, Liu H, Chen H, Cheng W, Dong S, et al. Elevated serum IL-39 in patients with ST-segment elevation myocardial infarction was related with left ventricular systolic dysfunction. Biomark Med. 2017;11:419\u201326.","journal-title":"Biomark Med"},{"key":"4172_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/eji.201546095","volume":"46","author":"X Wang","year":"2016","unstructured":"Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, et al. A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice. Eur J Immunol. 2016;46:1343\u201350.","journal-title":"Eur J Immunol"},{"key":"4172_CR21","volume":"7","author":"PM Bossuyt","year":"2023","unstructured":"Bossuyt PM, Deeks JJ, Leeflang MM, Takwoingi Y, Flemyng E. Evaluating medical tests: introducing the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Cochrane Database Syst Rev. 2023;7:ED000163.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-04172-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:57:12Z","timestamp":1775649432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-04172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4172"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-04172-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8017614\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Tianjin Medical University General Hospital approved the study, patients provided consent through an informed consent procedure reviewed by the committee, and the study was conducted in accordance with the ethical norms of the 1964 Declaration of Helsinki (RB2019-WZ-126).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"517"}}